Flavopiridol, the first cyclin-dependent kinase inhibitor to enter the clinic: current status
Year: 2000
Type: review
Author: Lloyd R Kelland
Institution: Institute of Cancer Research
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Keywords: flavopiridol, cyclin-dependent kinase inhibitors, CDK1, CDK2, CDK4, prostate cancer, head and neck cancer, non-Hodgkin lymphoma, leukemia, paclitaxel combination therapy, cisplatin combination therapy, antitumour activity, pharmacokinetics, glucuronidation, drug toxicity, apoptosis, P-TEFb, aldehyde dehydrogenase, glycogen phosphorylase
Open Access status: closed
OpenAlex ID: W2153640566
